Back to 
DnB Asset Management AS
DnB Asset Management AS
CNTA4 quarters
Position history for DnB Asset Management AS's holdings in CENTESSA PHARMACEUTICALS PLC
As of its Q1 2026 13F, DnB Asset Management held 10,394 shares of CNTA (Centessa Pharmaceuticals), worth $412,850. DnB Asset Management's 13F filings listed CNTA from Q3 2025 to Q1 2026, 3 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$217,959
Total Shares Change
-8,988
Quarter-by-Quarter History
Other major holders of CNTA: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP